Dr. Danijela Jelovac is board-certified medical oncologist with over a decade of professional experience. Dr. Jelovac earned her medical degree from the University of Belgrade before completing a postdoctoral research fellowship at the University of Maryland, where she worked on development of aromatase inhibitors and mechanisms of resistance. She then completed a residency in internal medicine at Union Memorial Hospital, followed by a fellowship in medical oncology at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University.
Dr. Jelovac joined the Johns Hopkins faculty in 2011 with a primary focus on the management and development of new approaches to treat breast and gynecologic malignancies. She has seen many women with aggressive breast cancer that requires neoadjuvant chemotherapy and has specific interest in a multi-disciplinary approach.
Dr. Jelovac served as investigator on many clinical trials, and published her work in numerous peer-reviewed publications and book chapters, and presented at national and international meetings.
In addition to clinical work, Dr. Jelovac held leadership positions as Chief of Medical Oncology at Tawam through Johns Hopkins International in collaboration with SKCCC, Access Physician Champion for SKCCC, and Assistant Director for Solid Tumor Ambulatory Services at SKCCC, Johns Hopkins University. She also has mentored many medical oncology fellows during their clinical training at Johns Hopkins.
Dr. Jelovac is a member of the American Society of Clinical Oncology, and Assistant Professor of Oncology at Johns Hopkins University.
Dr. Jelovac speaks Serbian and Croatian.
